1. Home
  2. STBA vs ZLAB Comparison

STBA vs ZLAB Comparison

Compare STBA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo S&T Bancorp Inc.

STBA

S&T Bancorp Inc.

HOLD

Current Price

$50.79

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$20.68

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STBA
ZLAB
Founded
1902
2013
Country
United States
China
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
STBA
ZLAB
Price
$50.79
$20.68
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$43.00
$49.60
AVG Volume (30 Days)
259.8K
851.8K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.29%
N/A
EPS Growth
2.35
38.46
EPS
0.94
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
$10.20
$9.75
Revenue Next Year
$4.14
$26.03
P/E Ratio
$54.04
N/A
Revenue Growth
N/A
15.33
52 Week Low
$34.01
$15.96
52 Week High
$51.01
$41.20

Technical Indicators

Market Signals
Indicator
STBA
ZLAB
Relative Strength Index (RSI) 69.87 63.50
Support Level $42.52 $16.84
Resistance Level N/A $21.33
Average True Range (ATR) 1.00 0.84
MACD -0.02 0.19
Stochastic Oscillator 92.28 93.46

Price Performance

Historical Comparison
STBA
ZLAB

About STBA S&T Bancorp Inc.

S&T Bancorp Inc is a financial holding company providing a full range of financial services to individuals and businesses in Pennsylvania and Ohio, including retail and commercial banking products, cash management, and trust and brokerage services. Through its subsidiary, it offers consumer, commercial, and small business banking services, including time and demand deposits, commercial and consumer loans, brokerage and trust services, and manages private investment accounts for individuals and institutions. The company earns revenue mainly from interest on loans and securities and fees for financial services, with net interest income as the principal source of revenue, and incurs expenses for deposits, funding sources, provision for credit losses, and operating costs.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: